Skip to product information
1 of 1

GeneBio Systems

Recombinant Mouse CD27 Ligand/TNFSF7 Protein(Fc Tag)

Recombinant Mouse CD27 Ligand/TNFSF7 Protein(Fc Tag)

SKU:PDMM100143

Regular price ¥154,400 JPY
Regular price Sale price ¥154,400 JPY
Sale Sold out
Shipping calculated at checkout.

Size:100μg

Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping:This product is provided as lyophilized powder which is shipped with ice packs.

Exp date:12 months

Category ID_II:Recombinant Proteins

Category ID_III:Immune Checkpoint Proteins

Abbreviation:CD27 Ligand/TNFSF7

Target Synonym:Tnfsf;Cd27l;Cd27lg;Tnfsf7;Cd70; TNFSF7

Research Areas:

Conjugation:

Target Species:Mouse

Expression Host:Mammalian

Application:

Fusion tag:C-Fc

UNIProt ID:O55237

Accession:O55237

Background:CD70 , a member of the tumor necrosis factor superfamily , is restricted to activated T-and B-lymphocytes and mature dendritic cells. Binding of CD70 to its receptor , CD27 , is important in priming , effector functions , differentiation and memory formation of T-cells as well as plasma and memory B-cell generation. Tight control of CD70 expression is required to prevent lethal immunodeficiency. By selective transcription , CD70 is largely confined to activated lymphocytes and dendritic cells (DC). As a type II transmembrane receptor , CD70 is normally expressed on a subset of B , T and NK cells , where it plays a costimulatory role in immune cell activation. Immunohistochemical analysis of CD70 expression in multiple carcinoma types. The restricted expression pattern of CD70 in normal tissues and its widespread expression in various malignancies makes it an attractive target for antibody-based therapeutics. Investigations to exploit CD70 as a cancer target have lead to the identification of potential antibody-based clinical candidates.

Concentration:

Activity:Not validated for activity

Sequence:Ser45-Ile193

Purity: > 90% as determined by reducing SDS-PAGE.

Formulation:Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.

Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.

Endotoxin:< 1.0 EU/mg of the protein as determined by the LAL method.

Calculated MW:41.3 kDa

ObservedMW:45 kDa

View full details